Catheter Precision Profit Margin

The latest profit margin for VTAK is -950.32% as of June 2026. That compares with -3208.5% in the prior-year period — up 70.4% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Catheter Precision's historical trend and sector peers before judging valuation or financial health.

Over the past year, VTAK's profit margin moved from -3208.5% to -950.32% — a 70.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Catheter Precision's valuation or profitability profile.

Against Healthcare companies, VTAK currently prints -950.32% for profit margin, while the sector average sits near 10.58%. That is roughly 9081.9% below the sector mean. Large gaps often invite a closer look at Catheter Precision's growth, margins, and balance sheet.

Profit Margin shows how effectively Catheter Precision converts resources into returns. At -950.32%, VTAK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3208.5% in the prior-year period — up 70.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VTAK's profit margin (-950.32%), review year-over-year change from -3208.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.